Comparing sedation methods during heart valve replacement for aortic stenosis
Compares sedation types in adults having aortic valve replacement, looking at breathing and delirium.
Key facts
- Who runs it
- Azienda Socio Sanitaria Territoriale Ovest Milanese
- Where
- Italy1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Prospective comparative randomized study of procedural sedation during TAVR (Transcatheter Aortic Valve Replacement)
- Status
- Recruiting
- Phase
- Phase 3
- People taking part
- 1 person, planned
- Started
- 9 Aug 2024
- Planned end
- 1 Jul 2026
- Type of study
- Interventional
- Record updated
- 1 July 2024
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with aortic stenosis (a narrowed heart valve) who are having TAVR, a valve replacement through a thin tube. It compares sedation methods during the procedure.
- Age
- 18 to 95 years.
- Sex
- All sexes. Women who could still become pregnant cannot join.
- Disease stage
- Aortic stenosis, with a planned TAVR procedure.
- Earlier treatment
- People who got an experimental drug in another study within 30 days of screening, or within 5 half-lives of that drug (whichever is longer), cannot join.
Main reasons for not taking part
- Acute stroke or other sudden brain blood-flow problems, or advanced heart failure.
- Allergy to the sedation drugs used or their other ingredients.
- Delirium (sudden confusion) before the procedure, or a psychiatric disorder treated with medicine.
- Other procedures at the same time as TAVR, such as Percutaneous Coronary Intervention.
- 2nd or 3rd degree heart block without a pacemaker, or uncontrolled low blood pressure.
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- Patients undergoing TAVR
- Age between 18 and 95 years
- Patient's agreement to participate in the protocol and to sign the informed consent form
Who cannot take part
- Participation in a clinical study where an experimental drug has been administered within 30 days of screening or within the 5 half-lives of the investigational drug (whichever period is longer)
- Concomitant procedures other than TAVR (e.g., Percutaneous Coronary Intervention)
- Acute cerebrovascular conditions
- Advanced heart failure
- allergies to sedative medications used or to any of the excipients
- Patients with psychiatric disorders on pharmacological therapy
- Women of potentially childbearing age (potentially childbearing age: any woman who has had her first menstruation until the post-menopausal period; postmenopausal woman: woman at least 45 years old who has not had menstrual periods for at least 12 months)
- Lack of informed consent
- presence of preoperative delirium
- Advanced 2nd or 3rd degree atrioventricular block in patients without a pacemaker
- Uncontrolled hypotension
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
- Determine if there are differences in the incidence of intra-procedural respiratory acidosis. - Determine if there are differences in the incidence of emergence delirium within the first 24 hours following the end of the procedure.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Official title
- Prospective comparative randomized study of procedural sedation during TAVR (Transcatheter Aortic Valve Replacement)
- Plain-language title
- Comparing sedation methods during heart valve replacement for aortic stenosisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 1 July 2024